These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27398098)

  • 1. Cheminformatics analysis of the AR agonist and antagonist datasets in PubChem.
    Hao M; Bryant SH; Wang Y
    J Cheminform; 2016; 8():37. PubMed ID: 27398098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying Activity Cliff Generators of PPAR Ligands Using SAS Maps.
    Méndez-Lucio O; Pérez-Villanueva J; Castillo R; Medina-Franco JL
    Mol Inform; 2012 Dec; 31(11-12):837-46. PubMed ID: 27476737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291.
    Kawata H; Arai S; Nakagawa T; Ishikura N; Nishimoto A; Yoshino H; Shiraishi T; Tachibana K; Nakamura R; Sato H
    Prostate; 2011 Sep; 71(12):1344-56. PubMed ID: 21308717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for androgen receptor agonists and antagonists: interaction of SPEED 98-listed chemicals and related compounds with the androgen receptor based on an in vitro reporter gene assay and 3D-QSAR.
    Tamura H; Ishimoto Y; Fujikawa T; Aoyama H; Yoshikawa H; Akamatsu M
    Bioorg Med Chem; 2006 Nov; 14(21):7160-74. PubMed ID: 16876421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cheminformatic Analysis and Machine Learning Modeling to Investigate Androgen Receptor Antagonists to Combat Prostate Cancer.
    Yu T; Nantasenamat C; Kachenton S; Anuwongcharoen N; Piacham T
    ACS Omega; 2023 Feb; 8(7):6729-6742. PubMed ID: 36844574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical landscape analysis with the OpenTox framework.
    Jeliazkova N; Jeliazkov V
    Curr Top Med Chem; 2012; 12(18):1987-2001. PubMed ID: 23110534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting PubChem for Virtual Screening.
    Xie XQ
    Expert Opin Drug Discov; 2010 Dec; 5(12):1205-1220. PubMed ID: 21691435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in cheminformatics methodologies and infrastructure to support the data mining of large, heterogeneous chemical datasets.
    Guha R; Gilbert K; Fox G; Pierce M; Wild D; Yuan H
    Curr Comput Aided Drug Des; 2010 Mar; 6(1):50-67. PubMed ID: 20370695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Cheminformatics in Drug Discovery.
    Lawless MS; Waldman M; Fraczkiewicz R; Clark RD
    Handb Exp Pharmacol; 2016; 232():139-68. PubMed ID: 26318607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMP-Cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs.
    Hu X; Hu Y; Vogt M; Stumpfe D; Bajorath J
    J Chem Inf Model; 2012 May; 52(5):1138-45. PubMed ID: 22489665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular scaffolds with high propensity to form multi-target activity cliffs.
    Hu Y; Bajorath J
    J Chem Inf Model; 2010 Apr; 50(4):500-10. PubMed ID: 20361784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extending the activity cliff concept: structural categorization of activity cliffs and systematic identification of different types of cliffs in the ChEMBL database.
    Hu Y; Bajorath J
    J Chem Inf Model; 2012 Jul; 52(7):1806-11. PubMed ID: 22758389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Learning-Based Structure-Activity Relationship Modeling for Multi-Category Toxicity Classification: A Case Study of 10K Tox21 Chemicals With High-Throughput Cell-Based Androgen Receptor Bioassay Data.
    Idakwo G; Thangapandian S; Luttrell J; Zhou Z; Zhang C; Gong P
    Front Physiol; 2019; 10():1044. PubMed ID: 31456700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Modeling of Estrogen Receptor Binding Agents Using Advanced Cheminformatics Tools and Massive Public Data.
    Ribay K; Kim MT; Wang W; Pinolini D; Zhu H
    Front Environ Sci; 2016 Mar; 4():. PubMed ID: 27642585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity cliffs in PubChem confirmatory bioassays taking inactive compounds into account.
    Hu Y; Maggiora GM; Bajorath J
    J Comput Aided Mol Des; 2013 Feb; 27(2):115-24. PubMed ID: 23296990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity cliffs and activity cliff generators based on chemotype-related activity landscapes.
    Pérez-Villanueva J; Méndez-Lucio O; Soria-Arteche O; Medina-Franco JL
    Mol Divers; 2015 Nov; 19(4):1021-35. PubMed ID: 26150300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicinal chemistry of adenosine, P2Y and P2X receptors.
    Jacobson KA; Müller CE
    Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a Computational Model for Androgen Receptor Activity.
    Kleinstreuer NC; Ceger P; Watt ED; Martin M; Houck K; Browne P; Thomas RS; Casey WM; Dix DJ; Allen D; Sakamuru S; Xia M; Huang R; Judson R
    Chem Res Toxicol; 2017 Apr; 30(4):946-964. PubMed ID: 27933809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PubChem atom environments.
    Hähnke VD; Bolton EE; Bryant SH
    J Cheminform; 2015; 7():41. PubMed ID: 26300985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.
    Yin D; He Y; Perera MA; Hong SS; Marhefka C; Stourman N; Kirkovsky L; Miller DD; Dalton JT
    Mol Pharmacol; 2003 Jan; 63(1):211-23. PubMed ID: 12488554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.